Robert Dunne – CEO, GlycoSelect

  • Presentation Title:

    From spin out to success – GlycoSeLect travels through the “valley of death”.

    Presentation Synopsis:

    It is estimated that 84% of companies spun out from Universities fail before they achieve financial break-even point. This is the “valley of death” so called by professional investors. GlycoSeLect is in this phase of company development. I will share our experience and hope to help other companies avoid our mistakes.

    Speaker Bio:

    Robert Dunne is a pharmaceutical industry executive with experience in multinational and SME companies. He has broad experience across many technical functions Quality Assurance, Regulatory Affairs, Operations and Product Development using this experience in a Business Development role. Among his corporate roles, he set up a program management function and has run successful project teams. While General Manager for Ireland, he set up a manufacturing plant and integrated an acquired R&D company into the corporate structure.

    Robert was a management team member of another university spin out, Alimentary Health, prior to joining GlycoSeLect, having identified its commercial potential from Enterprise Ireland’s Business Partner programme.




  • Organisers



  • Media Partners